Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
Yale University · Yale Cancer Center
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
690
total citations
- FWCI
- 37.19
- Percentile
- 100%
- References
- 59
Citations per year
Authors
19Topics & keywords
Topics
Keywords
- SIGLEC
- Immunotherapy
- Immune system
- Tumor microenvironment
- Cancer immunotherapy
- Biology
- Immunology
- Cancer research
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.